These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 8261680

  • 1. Serum ionized calcium, parathyroid hormone and phosphate in uremic patients during and between hemodialysis.
    Rudnicki M, Frølich A, Haaber A, Tvedegaard E, Thode J.
    Clin Nephrol; 1993 Oct; 40(4):225-9. PubMed ID: 8261680
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. Comparison between different dialysate calcium concentrations in nocturnal hemodialysis.
    Toussaint ND, Polkinghorne KR, Kerr PG, Somerville CA, Agar JW.
    Hemodial Int; 2007 Apr; 11(2):217-24. PubMed ID: 17403174
    [Abstract] [Full Text] [Related]

  • 4. Calcium balance and intact PTH variations during haemodiafiltration.
    Argilés A, Mion CM.
    Nephrol Dial Transplant; 1995 Nov; 10(11):2083-9. PubMed ID: 8643172
    [Abstract] [Full Text] [Related]

  • 5. Calcium exposure and removal in chronic hemodialysis patients.
    Sigrist M, McIntyre CW.
    J Ren Nutr; 2006 Jan; 16(1):41-6. PubMed ID: 16414440
    [Abstract] [Full Text] [Related]

  • 6. Calcium-PTH relationship in dialysis patients: the pitfalls of using a constant dialysate calcium concentration during the dynamic tests.
    De Cristofaro V, Samà F, Pagliari B, Colturi C, Sidoti A, Masa A, Filippini M, Comelli M, Pedrini L.
    Clin Nephrol; 1998 Feb; 49(2):113-20. PubMed ID: 9524782
    [Abstract] [Full Text] [Related]

  • 7. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
    Chudek J, Piecha G, Kokot F, Wiecek A.
    J Nephrol; 2003 Feb; 16(5):710-5. PubMed ID: 14733418
    [Abstract] [Full Text] [Related]

  • 8. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.
    Bro S, Brandi L, Olgaard K.
    Nephrol Dial Transplant; 1996 Aug; 11(8):1586-91. PubMed ID: 8856216
    [Abstract] [Full Text] [Related]

  • 9. Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients.
    Guh JY, Chen HC, Chuang HY, Huang SC, Chien LC, Lai YH.
    Am J Kidney Dis; 2002 Jun; 39(6):1245-54. PubMed ID: 12046038
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group.
    Weinreich T, Ritz E, Passlick-Deetjen J.
    Perit Dial Int; 1996 Jun; 16(3):260-8. PubMed ID: 8761540
    [Abstract] [Full Text] [Related]

  • 14. Effect of hypermagnesemia on circulating plasma parathyroid hormone in patients on regular hemodialysis therapy.
    McGonigle RJ, Weston MJ, Keenan J, Jackson DB, Parsons V.
    Magnesium; 1984 Jun; 3(1):1-7. PubMed ID: 6482508
    [Abstract] [Full Text] [Related]

  • 15. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM, Youssef AM, Zayoon MY.
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [Abstract] [Full Text] [Related]

  • 16. The relationship between serum calcium and phosphate levels and cardiac valvular procedures in the hemodialysis population.
    Rubel JR, Milford EL.
    Am J Kidney Dis; 2003 Feb; 41(2):411-21. PubMed ID: 12552504
    [Abstract] [Full Text] [Related]

  • 17. Acute effects of repetitive hemodialysis on circulating immunoreactive parathyroid hormone levels in uremic patients undergoing vitamin D (calcitriol) therapy.
    Bellazzi R, Romanini D, Bacchella L, Nai M, Aprile C, Santagostino M, De Vincenzi A.
    Nephron; 1991 Feb; 57(3):273-82. PubMed ID: 2017266
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Serum osteoprotegerin level is lower in peritoneal dialysis patients than in hemodialysis ones.
    Grzegorzewska AE, Młot M.
    Rocz Akad Med Bialymst; 2004 Feb; 49():193-6. PubMed ID: 15631342
    [Abstract] [Full Text] [Related]

  • 20. Direct effect of the correction of acidosis on plasma parathyroid hormone concentrations, calcium and phosphate in hemodialysis patients: a prospective study.
    Movilli E, Zani R, Carli O, Sangalli L, Pola A, Camerini C, Scolari F, Cancarini GC, Maiorca R.
    Nephron; 2001 Mar; 87(3):257-62. PubMed ID: 11287761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.